Catalyst Biosciences Inc.
13F holders, Q4 2024 (December 31)1holders
$12.13avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Catalyst Biosciences Inc. in their 13F filings. The largest holder was Parallel Advisors, LLC ($182).
- Company
- Catalyst Biosciences Inc.
- Filed as
- TARGACEPT INC (Q4 2024)
- CUSIP
- 14888D208
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $182 |
| Exits | 0 | $0 |
Ownership 1 holders
| Parallel Advisors, LLC | 0.00% | New | 15 | $182 |
"% of holder's portfolio" is CATALYST BIOSCIENCES INC's weight in each manager's 13F, not the share of Catalyst Biosciences Inc. the manager owns.